Tevogen Bio Holdings Inc.
TVGN
$7.00
-$2.54-26.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.35M | -26.28M | -31.04M | -31.20M | -35.36M |
| Total Depreciation and Amortization | 462.90K | 509.20K | 526.90K | 601.40K | 410.60K |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Other Non-Cash Items | 11.68M | 16.16M | 20.76M | 20.71M | 22.68M |
| Change in Net Operating Assets | -2.55M | -2.72M | -3.44M | -3.46M | -873.10K |
| Cash from Operations | -11.75M | -12.33M | -13.20M | -13.35M | -13.14M |
| Capital Expenditure | -64.40K | -64.40K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -64.40K | -64.40K | -- | -- | -- |
| Total Debt Issued | 3.40M | 3.40M | 3.40M | 4.40M | 3.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.24M | 8.36M | 6.60M | 2.50M | 2.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 2.00M | 6.00M | 8.80M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00K | -100.00K | -100.00K | 0.00 | 0.00 |
| Cash from Financing | 10.54M | 11.66M | 11.90M | 12.90M | 13.80M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.28M | -730.60K | -1.29M | -450.20K | 657.00K |